Results 181 to 190 of about 65,735 (288)

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Diagnostic Reference Levels in pediatric interventional cardiology: A multicenter study by the French cohort in HARMONIC project. [PDF]

PLoS One
Habib Geryes B, Bondet De La Bernardie S, Hascoet S, Geant C, Dauphin C, Douchin S, Rousseau J, Godart F, Pontvianne V, Ovaert Reggio C, Lefort B, Danvin A, Caer-Lorho S, Bernier MO, Bonnet D, Rage E.   +15 more
europepmc   +1 more source

European Society of Cardiology ST-segment Elevation Myocardial Infarction Guidelines in Perspective – Focused on Primary Percutaneous Coronary Intervention [PDF]

, 2011
Petr Kala
openalex   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Exploring magnetoelectric nanoparticles for advanced nano-electroporation and drug delivery in interventional cardiology. [PDF]

Nanoscale Adv
Tommasini A, Suarato G, Fiocchi S, Chiaramello E, Marrella A, Lenzuni M, Parazzini M, Cortese B, Ravazzani P.   +8 more
europepmc   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Artificial Intelligence in Cardiology: General Perspectives and Focus on Interventional Cardiology. [PDF]

Anatol J Cardiol
Biondi-Zoccai G, D'Ascenzo F, Giordano S, Mirzoyev U, Erol Ç, Cenciarelli S, Leone P, Versaci F.   +7 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Impact of new X-ray technology reducing patient and staff doses in interventional cardiology. [PDF]

Br J Radiol
Sánchez-Casanueva RM, Vano-Carruana E, Fernández-Soto JM.   +2 more
europepmc   +1 more source

Thrombolysis and interventional cardiology; experiences from the 80's

, 1992
Hans Bonnier
openalex   +1 more source